S2E18: Early Cancer Detection, Reimagined. Don't Be Dense, Get Checked with Liz Cormier-May, CEO of Mammogen

25 October 2024

Did you know that mammograms have remained virtually unchanged since their invention in 1913? It's no wonder they feel archaic!

Welloff Podcast promo: Season 2 Episode 18, “Early Cancer Detection, Reimagined,” with two hosts and guest Liz Cormier-May

In honor of Breast Cancer Awareness Month, Dr. Tara and Gina Simm welcome Liz Cormier-May, CEO of Mammogen, to the iHeartRadio studio. As a chemist and leader in the field, Liz is driving innovation in breast cancer detection, making it early, affordable, and accessible.


And here's the exciting part: a simple blood test for breast cancer detection could be available as early as next year! 


Tune in to find out how this groundbreaking development will change the game in cancer detection, what the categories are for dense breasts AND what the heck a Bi-Rads category is!


Mammogen is currently accepting patients for their clinical trial. Please visit mammogen.bio to sign up!


Listen to the full episode here:

https://www.buzzsprout.com/2307750/episodes/15954302

FDA Advisory Committee to Review Blood-Based Cancer Detection Test

26 August 2026
NBC 10 News featured Mammogen CEO Elizabeth Cormier-May in its coverage of the evolving landscape of blood-based cancer detection and an upcoming FDA advisory committee review of GRAIL’s Galleri test. Cormier-May shared her perspective on the significance of liquid biopsy technology and discussed how Mammogen’s approach differs by focusing specifically on earlier breast cancer detection. The story also highlights Mammogen’s blood-based test and its potential role in supporting women who may need additional testing following their annual mammogram. Read the full article on NBC 10 News →

RNA is the Next Frontier in Molecular Diagnostics

21 August 2026
The Scientist | Elizabeth Cormier-May In this contributed article for The Scientist, Mammogen Co-Founder and CEO Elizabeth Cormier-May explores why RNA may represent the next frontier in molecular diagnostics. The article examines how RNA can provide a dynamic view of what is happening biologically in real time, and why that information may be particularly valuable in early cancer detection. Cormier-May also discusses the importance of moving beyond simply detecting disease earlier toward generating insights that can meaningfully inform clinical decisions and patient care. Read the full article on The Scientist →

RNA is the Next Frontier in Molecular Diagnostics

21 August 2026
RNA opens a window into biology in motion, shifting molecular diagnostics from measuring more biology to finding the right biology in time to change patient care.